Theravance Biopharma (TBPH) Change in Account Payables (2016 - 2025)
Historic Change in Account Payables for Theravance Biopharma (TBPH) over the last 13 years, with Q3 2025 value amounting to $538000.0.
- Theravance Biopharma's Change in Account Payables rose 34454.55% to $538000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $759000.0, marking a year-over-year increase of 29663.21%. This contributed to the annual value of $750000.0 for FY2024, which is 1240000.0% up from last year.
- As of Q3 2025, Theravance Biopharma's Change in Account Payables stood at $538000.0, which was up 34454.55% from -$733000.0 recorded in Q2 2025.
- In the past 5 years, Theravance Biopharma's Change in Account Payables registered a high of $5.1 million during Q2 2021, and its lowest value of -$5.7 million during Q4 2021.
- Its 5-year average for Change in Account Payables is -$232578.9, with a median of -$2000.0 in 2024.
- Over the last 5 years, Theravance Biopharma's Change in Account Payables had its largest YoY gain of 34454.55% in 2025, and its largest YoY loss of 3655000.0% in 2025.
- Quarter analysis of 5 years shows Theravance Biopharma's Change in Account Payables stood at -$5.7 million in 2021, then skyrocketed by 34.46% to -$3.8 million in 2022, then skyrocketed by 90.75% to -$348000.0 in 2023, then soared by 326.44% to $788000.0 in 2024, then tumbled by 31.73% to $538000.0 in 2025.
- Its Change in Account Payables stands at $538000.0 for Q3 2025, versus -$733000.0 for Q2 2025 and $166000.0 for Q1 2025.